News

Filter

1 to 9 of 11 results

Actavis confirms generic Treanda patent challenge

Actavis confirms generic Treanda patent challenge

04-02-2014

US generics drug major Actavis confirms that it has filed an Abbreviated New Drug Application with the…

ActavisCephalonGenericsNorth AmericaOncologyPatentsTeva Pharmaceutical IndustriesTreandaUSA

FTC submits proposed Amicus Brief on "No-Authorized-Generic" commitments in drug patent settlements

21-08-2013

The US Federal Trade Commission has asked the US District Court for the District of New Jersey to accept…

ActavisEffexor XRGenericsLegalNorth AmericaPfizerPharmaceuticalTeva Pharmaceutical IndustriesWyeth

Teva and Actavis debut generic Viagra in Europe

24-06-2013

The patent on Viagra (sildenafil) expired last Friday (June 21) in the UK and some other European countries,…

ActavisEuropeGenericsMarkets & MarketingMen's HealthReproductivesildenafilTeva Pharmaceutical IndustriesViagra

Actavis settles with Mallinckrodt over Exalgo 32mg; Teva gains FDA OK for Adderall XR

14-02-2013

US generics drug major Actavis (NYSE: ACT) has reached a settlement with Mallinckrodt (NYSE: MKG) on…

ActavisAdderall XRExalgoGenericsMallinckrodtNeurologicalNorth AmericaPatentsRegulationShireTeva Pharmaceutical Industries

Watson confirms Velcade patent challenge; Mylan debuts generic Nordette

31-12-2012

US generic drugmaker Watson Pharmaceuticals (NYSE: WPI) on Friday confirmed that its subsidiary Actavis…

ActavisGenericsMarkets & MarketingMillennium PharmaceuticalsMylan LaboratoriesNordette 28North AmericaOncologyPatentsReproductiveTeva Pharmaceutical IndustriesVelcadeWatson Pharmaceuticals

Teva and Pfizer settle over Neurontin; France drops Champix; Actavis’ Aricept generic cleared

01-06-2011

Israeli generics giant Teva Pharmaceutical Industries (Nasdaq: TEVA) announced yesterday that patent…

ActavisAriceptChampixEisaiGenericsLegalMarkets & MarketingNeurologicalNeurontinPatentsPfizerPharmaceuticalTeva Pharmaceutical Industries

US Supreme Court agrees to hear generic drug labelling case; Teva files to stop generic Copaxone

13-12-2010

The USA’s highest court has agreed to hear appeals by Israel’s Teva Pharmaceutical Industries…

ActavisCopaxoneGenericsLegalMomenta PharmaceuticalsMylan LaboratoriesNeurologicalNorth AmericaNovartisPatentsPharmaceuticalRegulationSandozTeva Pharmaceutical Industries

US FDA rejects Teva’s second try to block generic Copaxone; Shire sues Actavis over Intuniv

14-05-2010

The US Food and Drug Administration has rejected a second Citizen Petition from Israel-based Teva Pharmaceutical…

ActavisCopaxoneGenericsIntunivNeurologicalPatentsPharmaceuticalRegulationShireTeva Pharmaceutical Industries

1 to 9 of 11 results

Back to top